Cytokinetics, Incorporated (KK3A)
Market Open
24 Feb, 09:47
XSTU 
€
57. 50
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-4.45 Eps
€ 57.5
Previous Close Day Range
57.5 57.5
Year Range
26.4 59
Want to track KK3A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KK3A earnings report is expected in 2 days (26 Feb 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KK3A Earnings Reports FAQ
What is the earnings per share (EPS) for KK3A?
The current EPS is -4.45.
What is the company's earnings growth rate?
Cytokinetics, Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-24, based on the KK3A's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cytokinetics, Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KK3A at this time, as Cytokinetics, Incorporated has no recent EPS data to calculate it.
